Retrospective Study of the Use of Belantamab Mafodotin (Blenrep®) in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) in Spain.
Clinical trial NCT05297240 · UNKNOWN
Trial details
- NCT number
- NCT05297240
- Sponsor
- PETHEMA Foundation
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-03-24
- Primary completion
- 2022-12-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.